These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 15960146

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Carvedilol, a novel cardiovascular agent, inhibits development of vascular and ventricular hypertrophy in spontaneously hypertensive rats.
    Ohlstein EH, Vickery L, Arleth A, Barone F, Sung CP, Camden A, McCartney L.
    Clin Exp Hypertens; 1994 Mar; 16(2):163-77. PubMed ID: 8193608
    [Abstract] [Full Text] [Related]

  • 23. Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.
    Wong VY, Laping NJ, Nelson AH, Contino LC, Olson BA, Gygielko E, Campbell WG, Barone F, Brooks DP.
    Br J Pharmacol; 2001 Nov; 134(5):977-84. PubMed ID: 11682445
    [Abstract] [Full Text] [Related]

  • 24. Progression of chronic adriamycin nephropathy in leukopenic rats.
    Ginevri F, Trivelli A, Mutti A, Bergamaschi E, Fabbretti G, Callea F, Salvidio G, Altieri P, Perfumo F, Ghiggeri GM.
    Nephron; 1993 Nov; 63(1):79-88. PubMed ID: 8446256
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Potentiation of natriuretic peptide action by the beta-adrenergic blocker carvedilol in hypertensive rats: a new antihypertensive mechanism.
    Yoshimoto T, Naruse M, Tanabe A, Naruse K, Seki T, Imaki T, Muraki T, Matsuda Y, Demura H.
    Endocrinology; 1998 Jan; 139(1):81-8. PubMed ID: 9421401
    [Abstract] [Full Text] [Related]

  • 27. Effect of carvedilol on renal hemodynamics and renal excretory function in spontaneously hypertensive rats.
    Gellai M, DeWolf R, Ruffolo RR.
    Pharmacology; 1990 Jan; 41(4):200-6. PubMed ID: 2080230
    [Abstract] [Full Text] [Related]

  • 28. Exposure to hydrocarbons and renal disease: an experimental animal model.
    Mutti A, Coccini T, Alinovi R, Toubeau G, Broeckaert F, Bergamaschi E, Mozzoni P, Nonclercq D, Bernard A, Manzo L.
    Ren Fail; 1999 Jan; 21(3-4):369-85. PubMed ID: 10416216
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of hypertension on the progress and prognosis of experimental focal glomerular sclerosis.
    Okuda S, Tsuruda H, Onoyama K, Oh Y, Motomura K, Fujishima M.
    Clin Sci (Lond); 1986 Jul; 71(1):23-9. PubMed ID: 3709073
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Protective effect of carvedilol on adriamycin-induced left ventricular dysfunction in children with acute lymphoblastic leukemia.
    El-Shitany NA, Tolba OA, El-Shanshory MR, El-Hawary EE.
    J Card Fail; 2012 Aug; 18(8):607-13. PubMed ID: 22858075
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pentoxifylline treatment enhances antihypertensive activity of captopril through hemorheological improvement in spontaneously hypertensive rats during development of arterial hypertension.
    Plotnikov MB, Shamanaev AY, Aliev OI, Sidekhmenova AV, Anishchenko AM, Arkhipov AM.
    J Am Soc Hypertens; 2017 Nov; 11(11):769-778. PubMed ID: 28989072
    [Abstract] [Full Text] [Related]

  • 35. Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
    Van den Branden C, Gabriels M, Vamecq J, Vanden Houte K, Verbeelen D.
    Nephron; 1997 Nov; 77(3):319-24. PubMed ID: 9375827
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Carvedilol treatment of kidney graft recipients with chronic rejection.
    Zezina L, Vessby B, Larsson E, Backman U, Fellström B.
    Clin Transplant; 1999 Dec; 13(6):484-90. PubMed ID: 10617238
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.